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The sarcoglycan (SG) complex, is composed by six glycosylated transmembrane pro-
teins (α-, β-, δ-, γ-, ε- and ζ-SG) and is closely linked to the major dystrophin-glycoprotein 
complex (DGC). The DGC is essential for membrane integrity during muscle contrac-
tion and provides a scaffold for important signalling molecules in all muscle cells. It is 
well known that Duchenne Muscular Dystrophy is caused by mutations in the dystro-
phin gene and is characterized by progressive muscle wasting. Cognitive impairments 
occur in approximately one third of Duchenne patients, highlighting a role for dystro-
phin in the nervous system. In particular, in neurons, dystrophin and some components 
of DGC, are associated with inhibitory GABAergic synapses and plays a key role in 
synapse function and plasticity. In addition, the DGC-complex is involved in blood-
brain barrier formation and maintenance and in water and ion homeostasis. Conflicting 
reports exist concerning possible expression of SGs in brain. Data suggested the pres-
ence of ε and ζ subunits in CNS; in fact, mutations in the gene encoding ε-sarcoglycan 
cause the neurogenic movement disorder called myoclonus-dystonia, suggesting its 
role in brain. So the aim of this study is the study of the presence and localization of 
the SG complex in the human cerebral cortex. Immunofluorescent analysis and reverse 
transcriptase polymerase chain reaction evaluation were performed for α-, β-, γ-, δ- and 
ε-SG. The results showed that these subunits are expressed in brain. Confocal immuno-
fluorescence microscopy evidenced that all tested proteins of DGC are localized in large 
neurones in cerebral cortex. An immunoreactivity was also associated with cells that 
astrocytes. These data suggest that α-β-δ-γ-ε-sarcoglycan may have a role in the organi-
zation of CNS synapses and in the modulation of blood brain-barrier.
